Back
NextEra Energy 10K Form
Sell
42
NEE
NextEra Energy
Last Price:
$72.82
Seasonality Move:
-0.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-23 | 10Q | NEE/NextEra Energy Quarterly |
2024-02-16 | 10K | NEE/NextEra Energy Annual |
2023-11-07 | 10Q | NEE/NextEra Energy Quarterly |
2023-07-26 | 10Q | NEE/NextEra Energy Quarterly |
2023-04-26 | 10Q | NEE/NextEra Energy Quarterly |
2023-02-17 | 10K | NEE/NextEra Energy Annual |
Receive NEE News And Ratings
See the #1 stock for the next 7 days that we like better than NEE
NEE Financial Statistics
Sales & Book Value
Annual Sales: | $28.1B |
---|---|
Cash Flow: | $2.2B |
Price / Cash Flow: | 27.66 |
Annual Sales: | $24.34 |
Price / Book: | 2.98 |
Profitability
EPS (TTM): | 3.37910 |
---|---|
Net Income (TTM): | $7B |
Gross Margin: | $18B |
Return on Equity: | 11.88% |
Return on Assets: | 3.86% |
NextEra Energy Earnings Forecast
Key NextEra Energy Financial Ratios
-
The Gross Profit Margin over the past 30 years for NEE is 63.94%.
-
The Selling, General & Administrative Expenses for NEE have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 45.47% of Operating Income.
-
The Net Earning history of NEE is 26.00% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 26 years.
NextEra Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Electric Utilities |
Sector: | Utilities |
Current Symbol: | NEE |
CUSIP: | 65339F |
Website: | nexteraenergy.com |
Debt
Debt-to-Equity Ratio: | 1.65 |
---|---|
Current Ratio: | 0.41 |
Quick Ratio: | 0.24 |
Price-to-Earnings
Trailing P/E Ratio: | 20.14 |
---|---|
Forward P/E Ratio: | 19.71 |
NEE Technical Analysis vs Fundamental Analysis
Sell
42
NextEra Energy (NEE)
is a Sell
Is NextEra Energy a Buy or a Sell?
-
NextEra Energy stock is rated a SellThe current NextEra Energy [NEE] share price is $72.49. The Score for NEE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.